Home
>
US Stocks
>
Inozyme Pharma Inc
Inozyme Pharma Inc
INZY

Inozyme Pharma Inc (INZY)

$9.421.51%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$9.8
Today Low/High$9.11 / $9.8
52 Week Low/High$8.84 / $29.46
Market Cap$224.31M

Company Details

Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization. Through the company's in-depth understanding of the biological pathways involved in mineralization, company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. It is well established that two genes, ENPP1 and ABCC6, play key roles in a critical mineralization pathway and that defects in these genes lead to abnormal mineralization. Inozyme is initially focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies.
OrganisationInozyme Pharma Inc
Employees38
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Inozyme Pharma Inc (INZY) share price today?

Can Indians buy Inozyme Pharma Inc (INZY) shares?

How can I buy Inozyme Pharma Inc (INZY) shares from India?

Can Fractional shares of Inozyme Pharma Inc (INZY) be purchased?

What are the documents required to start investing in Inozyme Pharma Inc (INZY) stocks?

We are a SEBI registered investement advisor